
Michael P. Cohen
Examiner (ID: 9928, Phone: (571)270-7402 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 956 |
| Issued Applications | 513 |
| Pending Applications | 126 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16391006
[patent_doc_number] => 20200331947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Methods of Preparing Steviol Glycosides and Uses of the Same
[patent_app_type] => utility
[patent_app_number] => 16/915932
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915932 | Methods of preparing steviol glycosides and uses of the same | Jun 28, 2020 | Issued |
Array
(
[id] => 16620069
[patent_doc_number] => 20210038722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
[patent_app_type] => utility
[patent_app_number] => 16/904824
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904824 | Cochleates made with soy phosphatidylserine | Jun 17, 2020 | Issued |
Array
(
[id] => 17988736
[patent_doc_number] => 20220354773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ROSEBUSH EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/622587
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622587 | ROSEBUSH EXTRACT | Jun 17, 2020 | Pending |
Array
(
[id] => 16734486
[patent_doc_number] => 10960107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Collagen matrix or granulate blend of bone substitute material
[patent_app_type] => utility
[patent_app_number] => 16/900262
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 12458
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900262 | Collagen matrix or granulate blend of bone substitute material | Jun 11, 2020 | Issued |
Array
(
[id] => 17790605
[patent_doc_number] => 20220249696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/602932
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602932 | TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS | Jun 11, 2020 | Pending |
Array
(
[id] => 16511420
[patent_doc_number] => 20200390677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => LEAVE-ON ORAL CARE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/899882
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899882 | Leave-on oral care compositions | Jun 11, 2020 | Issued |
Array
(
[id] => 17790605
[patent_doc_number] => 20220249696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/602932
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602932 | TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS | Jun 11, 2020 | Pending |
Array
(
[id] => 17392419
[patent_doc_number] => 11241407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy
[patent_app_type] => utility
[patent_app_number] => 16/897152
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 33555
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897152 | Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy | Jun 8, 2020 | Issued |
Array
(
[id] => 17775070
[patent_doc_number] => 20220241419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/617540
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617540 | Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor | Jun 1, 2020 | Pending |
Array
(
[id] => 17775070
[patent_doc_number] => 20220241419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/617540
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617540 | Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor | Jun 1, 2020 | Pending |
Array
(
[id] => 17775070
[patent_doc_number] => 20220241419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/617540
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617540 | Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor | Jun 1, 2020 | Pending |
Array
(
[id] => 17727726
[patent_doc_number] => 11384101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Oral care compositions
[patent_app_type] => utility
[patent_app_number] => 16/889093
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9271
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/889093 | Oral care compositions | May 31, 2020 | Issued |
Array
(
[id] => 16296249
[patent_doc_number] => 20200281972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA
[patent_app_type] => utility
[patent_app_number] => 16/881937
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881937 | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza | May 21, 2020 | Issued |
Array
(
[id] => 16435552
[patent_doc_number] => 20200352877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => BAKUCHIOL COMPOSITIONS FOR TREATMENT OF POST INFLAMMATORY HYPERPIGMENTATION
[patent_app_type] => utility
[patent_app_number] => 16/876333
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876333 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation | May 17, 2020 | Issued |
Array
(
[id] => 17747416
[patent_doc_number] => 20220225619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHOD AND PROCEDURE FOR OBTAINING NATURAL PYRETHRIN MICROBIOCAPSULES WITH HIGH STABILITY
[patent_app_type] => utility
[patent_app_number] => 17/611865
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611865 | METHOD AND PROCEDURE FOR OBTAINING NATURAL PYRETHRIN MICROBIOCAPSULES WITH HIGH STABILITY | May 17, 2020 | Issued |
Array
(
[id] => 16267399
[patent_doc_number] => 20200268886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Orally Dissolving Melatonin Formulation With Acidifying Agent That Renders Melatonin Soluble In Saliva
[patent_app_type] => utility
[patent_app_number] => 15/931029
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931029
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931029 | Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva | May 12, 2020 | Issued |
Array
(
[id] => 16267400
[patent_doc_number] => 20200268887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Orally Dissolving Melatonin Formulation With Acidifying Agent That Renders Melatonin Soluble In Saliva
[patent_app_type] => utility
[patent_app_number] => 15/931135
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931135 | Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva | May 12, 2020 | Issued |
Array
(
[id] => 16435524
[patent_doc_number] => 20200352849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment
[patent_app_type] => utility
[patent_app_number] => 16/868492
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868492 | Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment | May 5, 2020 | Abandoned |
Array
(
[id] => 16389709
[patent_doc_number] => 20200330650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => BIOCOMPATIBLE MOLDED PART
[patent_app_type] => utility
[patent_app_number] => 16/866395
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866395 | Biocompatible molded part | May 3, 2020 | Issued |
Array
(
[id] => 17748021
[patent_doc_number] => 20220226224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => DEODORANT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/608648
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/608648 | Deodorant composition | May 3, 2020 | Issued |